LTA.sub.4, hydrolase inhibitors
US6110944A · kind A · utility
6Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 1997 |
| Grant date | Aug 29, 2000 |
| Priority date | — |
| Expiry date | Mar 12, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds having the structure EQU Ar.sub.1 --Q--Ar.sub.2 --O--(CH.sub.2).sub.n --Z and pharmaceutically acceptable salts and stereoisomers thereof that are useful in the treatment of inflammatory diseases which are mediated by LTB.sub.4 production, such as psoriasis, ulcerative colitis, IBD, and asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.